Bruno Stankoff

Bruno Stankoff

Auto-generated profile, based on publicly available information

Bruno Stankoff

Sorbonne Université, Paris Brain Institute, CNRS, Inserm, France

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LJLaurent Jacob
Laurent Jacob
JNJose de Brito Neto
Jose de Brito Neto
SLStephanie Lenck
Stephanie Lenck
CCCeline Corcy
Celine Corcy
FBFarhat Benbelkacem
Farhat Benbelkacem
JTJean-Leon Thomas
Jean-Leon Thomas
Meningeal lymphatic vessels (MLVs) were identified in the dorsal and caudobasal regions of the dura mater, where they ensure waste product elimination and immune surveillance of brain tissues. Whether MLVs exist in the anterior part of the murine and human skull and how they connect with the glymphatic system and extracranial lymphatics remained unclear. Here, we used light-sheet fluorescence microscopy (LSFM) imaging of mouse whole-head preparations after OVA-A555 tracer injection into the cerebrospinal fluid (CSF) and performed real-time vessel-wall (VW) magnetic resonance imaging (VW-MRI) after systemic injection of gadobutrol in patients with neurological pathologies. We observed a conserved three-dimensional anatomy of MLVs in mice and humans that aligned with dural venous sinuses but not with nasal CSF outflow, and we discovered an extended anterior MLV network around the cavernous sinus, with exit routes through the foramina of emissary veins. VW-MRI may provide a diagnostic tool for patients with CSF drainage defects and neurological diseases.

1 October 2021 in Radiology
Verified
Journal Article
Closed access
Vito AG RiciglianoVito AG Ricigliano
Vito AG Ricigliano
EMEmanuele Morena
Emanuele Morena
ACAnnalisa Colombi
Annalisa Colombi
MTMatteo Tonietto
Matteo Tonietto
MHMariem Hamzaoui
Mariem Hamzaoui
BSBruno Stankoff
Bruno Stankoff
A combination of three-dimensional MRI and translocator protein PET demonstrated enlarged and inflamed choroid plexuses in patients with multiple sclerosis (MS), representing a potential imaging ma... Background Choroid plexuses (CPs) have been suggested as a key gateway for inflammation in experimental autoimmune encephalitis, but in vivo evidence of their involvement in multiple sclerosis (MS)...

7 July 2021 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
MSMaria Pia Sormani
Maria Pia Sormani
MSMarco Salvetti
Marco Salvetti
PLPierre Labauge
Pierre Labauge
ISIrene Schiavetti
Irene Schiavetti
HZHelene Zephir
Helene Zephir
CLCeline Louapre
Celine Louapre
We evaluated the effect of DMTs on Covid‐19 severity in patients with MS, with a pooled‐analysis of two large cohorts from Italy and France. The association of baseline characteristics and DMTs with Covid‐19 severity was assessed by multivariate ordinal‐logistic models and pooled by a fixed‐effect meta‐analysis. 1066 patients with MS from Italy and 721 from France were included. In the multivariate model, anti‐CD20 therapies were significantly associated (OR = 2.05, 95%CI = 1.39–3.02, p < 0.001) with Covid‐19 severity, whereas interferon indicated a decreased risk (OR = 0.42, 95%CI = 0.18–0.99, p = 0.047). This pooled‐analysis confirms an increased risk of severe Covid‐19 in patients on anti‐CD20 therapies and supports the protective role of interferon.

7 June 2020 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
Massimo FilippiMassimo Filippi
Massimo Filippi
PPPaolo Preziosa
Paolo Preziosa
DLDawn Langdon
Dawn Langdon
HLHans Lassmann
Hans Lassmann
FPFriedemann Paul
Friedemann Paul
MRMaria A. Rocca
Maria A. Rocca

3 May 2023 in Annals of Neurology
Verified
Journal Article
Open access
MHMariem Hamzaoui
Mariem Hamzaoui
JGJeanne Garcia
Jeanne Garcia
GBGiacomo Boffa
Giacomo Boffa
ALAndrea Lazzarotto
Andrea Lazzarotto
MAMartina Absinta
Martina Absinta
BSBruno Stankoff
Bruno Stankoff
Objective: To determine the prognostic value of persisting neuroinflammation in multiple sclerosis (MS) lesions, we developed a 18 kDa‐translocator‐protein‐positron emission tomography (PET) ‐based classification of each lesion according to innate immune cell content and localization. We assessed the respective predictive value of lesion phenotype and diffuse inflammation on atrophy and disability progression over 2 years.Methods: Thirty‐six people with MS (disease duration 9 ± 6 years; 12 with relapsing–remitting, 13 with secondary‐progressive, and 11 with primary‐progressive) and 19 healthy controls (HCs) underwent a dynamic [18F]‐DPA‐714‐PET. At baseline and after 2 years, the patients also underwent a magnetic resonance imaging (MRI) and neurological examination. Based on a threshold of significant inflammation defined by a comparison of [18F]‐DPA‐714 binding between patients with MS and HCs, white matter lesions were classified as homogeneously active (active center), rim‐active (inactive center and active periphery), or nonactive. Longitudinal cortical atrophy was measured using Jacobian integration.Results: Patients with MS had higher innate inflammation in normal‐appearing white matter (NAWM) and cortex than HCs (respective standardized effect size = 1.15, 0.89, p = 0.003 and < 0.001). Out of 1,335 non‐gadolinium‐enhancing lesions, 53% were classified as homogeneously‐active (median = 17 per patient with MS), 6% rim‐active (median = 1 per patient with MS), and 41% non‐active (median = 14 per patient with MS). The number of homogenously‐active lesions was the strongest predictor of longitudinal changes, associating with cortical atrophy (β = 0.49, p = 0.023) and Expanded Disability Status Scale (EDSS) changes (β = 0.35, p = 0.023) over 2 years. NAWM and cortical binding were not associated to volumetric and clinical changes.Interpretation: The [18F]‐DPA‐714‐PET revealed that an unexpectedly high proportion of MS lesions have a smoldering component, which predicts atrophy and clinical progression. This suggests that following the acute phase, most lesions develop a chronic inflammatory component, promoting neurodegeneration and clinical progression. ANN NEUROL 2023;94:366–383

4 November 2019 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
SASylvain Auvity
Sylvain Auvity
MTMatteo Tonietto
Matteo Tonietto
FCFabien Caillé
Fabien Caillé
BBBenedetta Bodini
Benedetta Bodini
MBMichel Bottlaender
Michel Bottlaender
BSBruno Stankoff
Bruno Stankoff